Biopharma companies should not overlook India's growing market.
How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?
The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
New regulation offers patients in Brazil greater access to experimental drugs.
Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.
The pharmaceutical industry grows despite conflict in the Middle East.
Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.
The bio-pharmaceutical business outlook in South Korea remains positive
A unique demographic and payer mix make ASEAN an increasingly attractive region.